Senhwa Biosciences, Inc. (TPEX:6492)

Senhwa Biosciences Statistics

Total Valuation

TPEX:6492 has a market cap or net worth of TWD 4.08 billion. The enterprise value is 3.21 billion.

Market Cap	4.08B
Enterprise Value	3.21B

Important Dates

The next estimated earnings date is Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6492 has 89.19 million shares outstanding.

Current Share Class	89.19M
Shares Outstanding	89.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.04%
Owned by Institutions (%)	0.11%
Float	68.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4,080.24
PB Ratio	4.52
P/TBV Ratio	4.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.54
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.38, with a Debt / Equity ratio of 0.03.

Current Ratio	38.38
Quick Ratio	38.11
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-466.27

Financial Efficiency

Return on equity (ROE) is -26.64% and return on invested capital (ROIC) is -17.08%.

Return on Equity (ROE)	-26.64%
Return on Assets (ROA)	-16.84%
Return on Invested Capital (ROIC)	-17.08%
Return on Capital Employed (ROCE)	-31.72%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6492 has paid 1.28 million in taxes.

Income Tax	1.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.70% in the last 52 weeks. The beta is 0.95, so TPEX:6492's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-7.70%
50-Day Moving Average	40.27
200-Day Moving Average	37.91
Relative Strength Index (RSI)	59.15
Average Volume (20 Days)	945,576

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6492 had revenue of TWD 1.00 million and -278.44 million in losses. Loss per share was -3.12.

Revenue	1.00M
Gross Profit	530,000
Operating Income	-291.88M
Pretax Income	-277.16M
Net Income	-278.44M
EBITDA	-289.67M
EBIT	-291.88M
Loss Per Share	-3.12

Balance Sheet

The company has 894.14 million in cash and 26.22 million in debt, giving a net cash position of 867.92 million or 9.73 per share.

Cash & Cash Equivalents	894.14M
Total Debt	26.22M
Net Cash	867.92M
Net Cash Per Share	9.73
Equity (Book Value)	903.07M
Book Value Per Share	10.13
Working Capital	877.19M

Cash Flow

Operating Cash Flow	-265.58M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	53.00%
Operating Margin	-29,188.30%
Pretax Margin	-27,716.40%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6492 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.82%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6492 has an Altman Z-Score of 57.37 and a Piotroski F-Score of 1.

Altman Z-Score	57.37
Piotroski F-Score	1